Lab Norata
@LabNorata
Laboratory of Pharmacology of Cardioimmunometabolic Disorders, University of Milan - Department of Pharmacological and Biomolecular Sciences (DiSFeB)
🔥Honored to speak at the #EAS Advanced Course on Non-Classical Risk Factors, on upfront therapeutic perspectives in cardio-renal syndrome. Thanks to @society_eas, to the organizers, for fueling this fight. ⚔️science is a weapon, innovation is a creed. @DaniloNorata @LabNorata
A terrific EAS Advanced Course on Non-Classical Risk Factor. I would like to sincerely thank the @society_eas for the opportunity to organize this event and for their continuous commitment in education. The meeting have been truly inspiring. Thanks to all friends a and colleagues
Congrats to the Best Young Investigator Prize Winners – SISA Lombardia/SITECs 2025! 🏆 A special shout-out to Moretti Arianna, Laura Gullà and Marta Iaia for receiving the Best Young Investigator Prize at the SISA Lombardia/SITECs 2025 Meeting linkedin.com/posts/giuseppe…
Very looking forward to welcome all the participants in Milan on Oct 30 for the EAS Advanced Course on non‑classical risk factors 🇮🇹meeting with leading experts on atherosclerosis and beyond @cj_binder @society_eas @LabNorata @AndreaBaragetti @Charis_Oxford @fabri_bon87
Join us in Milan on October 30, for the EAS Advanced Course on non-classical risk factors. Held at the Hilton Milano 🇮🇹, this full-day event brings together leading experts to explore emerging topics in cardiovascular science - including MASLD, cardio-renal syndrome,…
🎓 PhD Graduation – Università degli Studi di Milano 🎓 Honored of our PhD graduates. Congratulations to all our new PhDs — the future of science is in great hands! 🌟@DaniloNorata linkedin.com/posts/giuseppe…
Hot off the press! 🚀 Thrilled to share our latest publication from the lab. An exciting step forward made possible by the incredible work of our team. 🧠🔬 A huge congratulations to all contributors! 🥳 Dive into the details and enjoy the read: 📖
🧬 Thrilled to share our new publication in Molecular Metabolism! Our findings reveal a role of mitochondrial fusion in promoting lipid imbalance and vascular disease, suggesting that mitochondrial dynamics could be a novel therapeutic target in #CVD eur02.safelinks.protection.outlook.com/?url=https%3A%…
Proud to share our new paper! … Perfect birthday “gift” ✨ Thanks to everyone who made this possible.
Just returned from the 48th European Lipoprotein Club Meeting in Tutzing. It was an inspiring few days of science, discussion, and connection. 🔬💊 Grateful for the opportunity and the feedback received! ✨ #ELC2025 @society_eas @LabNorata
Join us in Milan on October 30, for the EAS Advanced Course on non-classical risk factors. Held at the Hilton Milano 🇮🇹, this full-day event brings together leading experts to explore emerging topics in cardiovascular science - including MASLD, cardio-renal syndrome,…
✌️Extra-hepatic effects of anti-pcsk9 options emerging from trials! 😎lowering LDLc as much as possible is 💯safe! proposing position for investors and developers of the novel formulations! Glad to share with @lore_ddlt @DaniloNorata @LabNorata tandfonline.com/doi/full/10.10…
🚀 New Review Alert! 🚀 Targeting PCSK9 beyond the liver. PCSK9 is well known for its role in cholesterol metabolism, but emerging evidence suggests its impact extends beyond the liver. @DaniloNorata @AndreaBaragetti linkedin.com/posts/lorenzo-…
We are excited to share our latest research highlighting how neuronal PCSK9 influences synaptic ApoER2 localization, offering new insights into its role in the brain. sciencedirect.com/science/articl… @DaniloNorata @lore_ddlt
Awareness of molecular diff in ath btw ♂️ and ♀️ advances understanding of hormones, sex chromosomes, & CV risk. It helps stratify risk, guide hormone therapy in post-menopause, and impacts transgender individuals #HerHeartMatters 🔗doi.org/10.1016/j.athe… @society_eas @LabNorata
Proud of our team member @lore_ddlt for being Awarded with a scholarship at the #KSHeartFail25 on the role of mitochondrial metabolism in the interplay between heart and the liver! @KeystoneSymp! Many compliments to all the awardee!
Glad to share this outcome🚀Multinational alliance 🇮🇹🇳🇱🇷🇺to prove potent performance of FGF5 to identify FH when 💸💸genetics is not available💥💥 The potential of A.I. is endless🤖 In search of biological relevance🧬🧫 @AL_Catapano academic.oup.com/eurheartj/adva…
The new manuscript from the lab and @AndreaBaragetti is out!!! Enjoy the read of Exploring neutrophils as therapeutic targets in cardiometabolic diseases: Trends in Pharmacological Sciences cell.com/trends/pharmac…
Huge presentation held by @DaniloNorata at SISA italian society of Atherosclerosis💣💥. Super set of data🚀 @FraaFantini. Keep posted🤙 @LabNorata
United States Trends
- 1. Northern Lights 31.8K posts
- 2. #DWTS 48.6K posts
- 3. #Aurora 6,489 posts
- 4. Justin Edwards 1,918 posts
- 5. Louisville 16.5K posts
- 6. Andy 59.5K posts
- 7. #RHOSLC 6,005 posts
- 8. #OlandriaxHarpersBazaar 4,070 posts
- 9. Lowe 12.3K posts
- 10. Oweh 1,934 posts
- 11. Kentucky 24.7K posts
- 12. Elaine 39.9K posts
- 13. Creighton 1,758 posts
- 14. JT Toppin N/A
- 15. Celtics 12K posts
- 16. #WWENXT 16.4K posts
- 17. Robert 98.3K posts
- 18. Dylan 30.4K posts
- 19. Gonzaga 2,310 posts
- 20. Jordan Walsh N/A
Something went wrong.
Something went wrong.